出售美国医疗器械业务,药明康德重塑业务版图

MedTrend医趋势
Jan 20, 2025

1月17日,中国CRO巨头药明康德宣布,出售美国医疗器械测试业务。其将位于佐治亚州亚特兰大和明尼苏达州圣保罗的两个工厂出售给医疗技术测试、临床和监管咨询公司NAMSA。此次交易的财务细节目前尚未披露。值得关注的是,这已是一个月内,药明系第三次出售海外业务。2024年12月24日,宣布出售在美国、英国的两个细胞基因治疗公司;而后又出售了其持有的药明合联的部分股票获益超20亿元。2025年1月6日,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10